Repeated Intranasal Oxytocin Paradoxically Reduces Social Behavior in Mice
While acute intranasal oxytocin boosted limbic connectivity in mice, repeated 7-day dosing caused widespread brain connectivity changes and paradoxically reduced social interaction and communication.
Quick Facts
What This Study Found
Acute intranasal oxytocin focally enhanced limbic connectivity, while repeated 7-day dosing caused widespread brain connectivity reconfiguration with paradoxical reduction in social behavior.
Key Numbers
1 acute dose vs 7 daily doses; acute boosted limbic connectivity; repeated caused widespread cortical-limbic coupling and reduced social behavior
How They Did This
fMRI-based circuit mapping in adult mice comparing acute versus 7-day repeated intranasal oxytocin, with cerebral blood volume mapping, functional connectivity analysis, and social behavior testing.
Why This Research Matters
Intranasal oxytocin is being tested for autism and social impairment. This study shows repeated dosing may have opposite effects to single doses, potentially explaining inconsistent clinical trial results.
The Bigger Picture
This challenges the assumption that "more oxytocin = more social." The brain adapts to repeated oxytocin exposure with network-level changes that may actually impair the behaviors oxytocin is meant to improve.
What This Study Doesn't Tell Us
Mouse model — human brain connectivity may respond differently; 7-day protocol is short-term; dosing may not match clinical intranasal protocols; social behaviors measured may not fully capture human social cognition.
Questions This Raises
- ?Do these paradoxical effects occur in humans receiving long-term intranasal oxytocin?
- ?Is there an optimal dosing schedule that maintains pro-social effects without network reconfiguration?
- ?Could intermittent rather than daily dosing avoid the connectivity changes seen with repeated administration?
Trust & Context
- Key Stat:
- Paradoxical social reduction Repeated 7-day intranasal oxytocin decreased social interaction despite widespread brain connectivity increases
- Evidence Grade:
- Novel fMRI findings with behavioral validation in mice, but preliminary and potentially divergent from human responses to intranasal oxytocin.
- Study Age:
- Published in 2020; clinical oxytocin trials continue to show mixed results, consistent with the dosing-dependent effects found here.
- Original Title:
- Acute and Repeated Intranasal Oxytocin Differentially Modulate Brain-wide Functional Connectivity.
- Published In:
- Neuroscience, 445, 83-94 (2020)
- Authors:
- Pagani, Marco, De Felice, Alessia, Montani, Caterina, Galbusera, Alberto, Papaleo, Francesco, Gozzi, Alessandro
- Database ID:
- RPEP-05046
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can too much oxytocin reduce social behavior?
In mice, repeated daily intranasal oxytocin for 7 days paradoxically reduced social interaction and communication, despite increasing brain connectivity — suggesting more is not always better.
Should intranasal oxytocin be used long-term for autism?
This study raises caution — repeated dosing changed brain connectivity patterns differently from single doses and reduced social behavior in mice. Clinical dosing protocols may need careful design.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05046APA
Pagani, Marco; De Felice, Alessia; Montani, Caterina; Galbusera, Alberto; Papaleo, Francesco; Gozzi, Alessandro. (2020). Acute and Repeated Intranasal Oxytocin Differentially Modulate Brain-wide Functional Connectivity.. Neuroscience, 445, 83-94. https://doi.org/10.1016/j.neuroscience.2019.12.036
MLA
Pagani, Marco, et al. "Acute and Repeated Intranasal Oxytocin Differentially Modulate Brain-wide Functional Connectivity.." Neuroscience, 2020. https://doi.org/10.1016/j.neuroscience.2019.12.036
RethinkPeptides
RethinkPeptides Research Database. "Acute and Repeated Intranasal Oxytocin Differentially Modula..." RPEP-05046. Retrieved from https://rethinkpeptides.com/research/pagani-2020-acute-and-repeated-intranasal
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.